Feed HIPH
Summary
29 / 100 · Bulios Score
Valuation 65Growth -Profitability -Quality 0Debt 46Stability 0
What speaks for it
None of the indicators we track stands out on the positive side.
What to watch
- Revenue fell by 90% a year over the last 3 years.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedIs it growing?
Revenue (USD)
20202021202220232024
Diluted EPS (USD)
20202021202220232024
Revenue fell by 90% a year over the last 3 years.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $147.5K.
Profitability in detailIs it financially healthy?
Debt is a burdenCash and short-term investments $55.4K
Debt $2.00M
Free cash flow over 12 months -$144.7K
Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.